Document is current
Any future updates will be listed below
-
Authors
Aras, Omer https://orcid.org/0000-0003-1758-0542
Demirdag, Cetin
Kommidi, Harikrishna
Pavlova, Ina
Boyko, Vitaly
Lundon, Dara J.
Ting, Richard
Tewari, Ashutosh
Akin, Oguz
Sayman, Haluk B
-
Funding
Funding for this research was provided by:
National Cancer Institute (P30 CA008748)
- License Information
-
More Information
Article History
Received: 5 February 2021
Accepted: 28 March 2021
First Online: 16 April 2021
Declarations
:
: The patient was enrolled in and provided informed consent for a clinical trial of <sup>18</sup>F-BF3-Cy3-ACUPA or non-radioactive Cy7-ACUPA and <sup>68</sup>Ga-PSMA positron emission tomography/magnetic resonance imaging (PET/MRI) approved by the institutional review board at Cerrahpasa University School of Medicine (protocol #-29281604.01.01-139206). Informed consent was obtained from the participant included in the study.
: Richard Ting and Omer Aras are minor stakeholders in Trace Imaging Technologies. The other authors declare that they have no conflict of interest.
